Reportlinker Adds Preventive Healthcare Technologies, Products and Markets

Tuesday 3rd of November 2009 11:07

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Preventive Healthcare Technologies, Products and Markets

http://www.reportlinker.com/p0157458/Preventive-Healthcare-Technologies-Products-and-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014, and 2014 to 2019

An overview of preventive healthcare functions, including early detection, prophylaxis, prevention of errors in therapy, and chronic care management

A breakdown of the market for early detection and screening products, including prenatal and neonatal tests, pediatric tests, and adult tests for both sexes

Detailed company profiles and a patent analysis.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY BACKGROUND 1

GOALS AND OBJECTIVES 2

INTENDED AUDIENCE 2

SCOPE OF REPORT 3

METHODOLOGY 4

AUTHOR'S CREDENTIALS 4

RELATED BCC REPORTS 5

BCC ONLINE SERVICES 5

DISCLAIMER 6

Chapter-2: SUMMARY

SUMMARY TABLE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, THROUGH 2014 ($ MILLIONS) 7

SUMMARY FIGURE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS) 8

Chapter-3: OVERVIEW OF PREVENTIVE HEALTHCARE

DEFINITIONS 9

PREVENTIVE HEALTHCARE FUNCTIONS 9

EARLY DETECTION 9

TABLE 1 U.S. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY RECOMMENDED SCREENING PROCEDURES 10

Personalized Screening 11

Automated Screening 12

Other New Screening Technologies 12

PROPHYLAXIS 12

PREVENTION OF ERRORS, ADVERSE EFFECTS, AND COMPLICATIONS FROM MEDICAL TREATMENT 13

CHRONIC DISEASE MANAGEMENT 14

ENABLING TECHNOLOGIES 15

GENOMICS/PROTEOMICS/CYTOMICS 15

Genomics 15

Genomics (Continued) 16

Proteomics 17

Cytomics 18

NANOTECHNOLOGY 18

Nanomaterials 19

Nanodevices 20

INFORMATION TECHNOLOGIES 21

Electronic Prescribing Systems 21

Clinical Decision Support Systems 21

AUTOMATION 22

Wireless Technologies 22

Sensors 23

Robotics 24

Artificial Intelligence and Decision Support 24

TABLE 2 APPLICATIONS OF ARTIFICIAL INTELLIGENCE TO PREVENTIVE HEALTHCARE 25

RFID/Barcoding 25

END USER SEGMENTS 26

HOSPITALS 26

PHYSICIAN PRACTICES 27

LONG-TERM CARE FACILITIES 27

MILITARY 27

HEALTH INSURERS 28

EMPLOYERS 29

CONSUMERS 29

FIGURE 1 PROJECTED U.S. POPULATION, 2008-2019 (MILLIONS) 30

Persons Requiring Screening and Early Detection Services 30

Persons Requiring Prophylaxis 31

TABLE 3 TARGET GROUPS FOR SELECTED VACCINES, 2008 (MILLIONS) 31

Persons with Chronic Illness 31

Hypertension 32

Diabetes 32

High Cholesterol Levels 33

Heart Disease 34

Asthma 34

MARKET SUMMARY 35

TABLE 4 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES BY FUNCTION, THROUGH 2014 ($ MILLIONS) 35

FIGURE 2 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES MARKET SHARES BY FUNCTION, 2008-2014 (%) 36

Chapter-4: MARKET ENVIRONMENT FOR PREVENTIVE HEALTHCARE

FEDERAL GOVERNMENT INITIATIVES 37

CENTERS FOR MEDICARE AND MEDICAID SERVICES 37

Medicare 37

Medicaid 38

SCHIP 38

OTHER FEDERAL PREVENTIVE-CARE PROGRAMS 39

Immunization Grant (Section 317) Program 39

National Breast and Cervical Cancer Early Detection Program 39

PROPOSED U.S. HEALTHCARE SYSTEM RESTRUCTURING 40

RELATED FEDERAL INITIATIVES 41

ETHICAL CONCERNS 42

Chapter-5: TRENDS IN THE HEALTHCARE INDUSTRY

RISING HEALTHCARE COSTS 43

FIGURE 3 TOTAL U.S. HEALTHCARE EXPENDITURES, 1968-2008 ($ BILLIONS IN 2008 DOLLARS) 43

FIGURE 4 PER-CAPITA U.S. HEALTHCARE EXPENDITURES, 1968-2008 ($ BILLIONS IN 2008 DOLLARS) 44

FIGURE 5 U.S. HEALTHCARE EXPENDITURES AS A PERCENTAGE OF REAL GDP, 1968 AND 2008 (2008 $ BILLIONS) 45

PREVENTIVE HEALTHCARE AND OVERALL MEDICAL EXPENDITURES 45

FIGURE 6 U.S. EXPENDITURES ON PREVENTIVE VS. OTHER TYPES OF HEALTHCARE, 2008 ($ BILLIONS) 46

PREVENTIVE HEALTHCARE ... (CONTINUED) 47

HEALTH INSURANCE COVERAGE AND REIMBURSEMENT 48

MEDICAL EDUCATION 49

HEALTHCARE PROFESSIONALS' ATTITUDES 50

PATIENT ATTITUDES 51

ECONOMIC ENVIRONMENT 52

EMPLOYMENT TRENDS 52

FIGURE 7 TRENDS IN U.S. NON-FARM PAYROLL EMPLOYMENT (000 WORKERS) 53

IMPACT OF ECONOMIC TRENDS ON EMPLOYER HEALTH COVERAGE 54

FIGURE 8 TRENDS IN EMPLOYER-SPONSORED HEALTH INSURANCE, 2000-2008 (PERCENT OF U.S. COMPANIES OFFERING HEALTH INSURANCE) 54

FIGURE 8 (CONTINUED) 55

Chapter-6: EARLY DETECTION AND SCREENING: TECHNOLOGIES, PRODUCTS AND MARKETS, 2008âEUR"2014

SUMMARY 56

FIGURE 9 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTON TECHNOLOGIES, 2008-2014 ($ MILLIONS) 56

TECHNOLOGIES AND PRODUCTS 57

PERSONALIZED MEDICINE 57

Genetic Testing 57

Genetic Testing (Continued) 58

Suppliers of Genetic Tests 59

TABLE 5 SUPPLIERS OF GENETIC TESTS 59

Proteomic Tests 59

Proteomic Tests (Continued) 60

Suppliers of Proteomic Tests 61

TABLE 6 SUPPLIERS OF PROTEOMIC TESTS 61

AUTOMATED SCREENING 61

Telehealth Kiosks 61

Telehealth Kiosks (Continued) 62

Suppliers of Telehealth Kiosks 63

TABLE 7 SUPPLIERS OF TELEHEALTH KIOSKS 63

Eye Health Kiosks 63

Automated Drug Testing 64

Suppliers of Automated Drug Testing Equipment 65

TABLE 8 DEVELOPERS AND SUPPLIERS OF AUTOMATED DRUG TESTING EQUIPMENT 65

OTHER ADVANCED SCREENING TESTS 65

Breast Cancer Screening 65

Molecular Breast Imaging 65

Automated Whole Breast Ultrasound 66

CT Colonography 67

Automated Skin Cancer Screening 68

Suppliers 69

TABLE 9 DEVELOPERS AND SUPPLIERS OF OTHER ADVANCED HEALTH SCREENING TECHNOLOGIES 69

MARKETS 69

SUMMARY 69

TABLE 10 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTION TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 70

FIGURE 10 EARLY DETECTION AND SCREENING PRODUCT SEGMENTS, 2008-2014 (%) 70

FIGURE 10 (CONTINUED) 71

PERSONALIZED MEDICINE 71

TABLE 11 U.S. MARKET FOR PERSONALIZED PREVENTIVE MEDICINE ($ MILLIONS) 71

Genetic Screening 71

FIGURE 11 U.S. GENETIC TESTING MARKET SHARES, 2008 (%) 72

TABLE 12 U.S. MARKET FOR GENETIC SCREENING TESTS ($ MILLIONS) 73

Proteomic Screening 73

TABLE 13 U.S. MARKET FOR PROTEOMIC SCREENING TESTS ($ MILLIONS) 73

AUTOMATED SCREENING 74

TABLE 14 U.S. MARKET FOR AUTOMATED HEALTH ASSESSMENT AND SCREENING SYSTEMS BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS) 74

Telehealth Kiosks 74

TABLE 15 NEW TELEHEALTH KIOSK SALES AND LEASE REVENUES, 2014 (UNITS/$) 75

Eye Health Kiosks 75

TABLE 16 U.S. MARKET FOR AUTOMATED EYE HEALTH KIOSKS, THROUGH 2014 ($ MILLIONS) 75

Automated Drug Testing 76

FIGURE 12 AUTOMATED TEST EQUIPMENT SHARE OF DRUG TESTING MARKET, 2008 (%) 76

FIGURE 13 DRUGS OF ABUSE VS. THERAPEUTIC DRUG TESTING SHARES OF AUTOMATED DRUG TESTING EQUIPMENT MARKET, 2008 (%) 77

TABLE 17 U.S. MARKET FOR AUTOMATED DRUG TESTING SYSTEMS, THROUGH 2014 ($ MILLIONS) 78

OTHER ADVANCED SCREENING AND EARLY DETECTION TECHNOLOGIES 78

TABLE 18 U.S. MARKET FOR OTHER ADVANCED SCREENING TECHNOLOGIES BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS) 79

BREAST CANCER SCREENING 79

TABLE 19 U.S. MARKET FOR ADVANCED BREAST CANCER SCREENING SYSTEMS, THROUGH 2014 ($ MILLIONS) 79

Molecular Breast Imaging 80

TABLE 20 U.S. MARKET FOR MOLECULAR BREAST IMAGING SYSTEMS, THROUGH 2014 ($ MILLIONS) 80

ABUS 80

TABLE 21 U.S. MARKET FOR AUTOMATED WHOLE BREAST ULTRASOUND SYSTEMS, THROUGH 2014 ($ MILLIONS) 81

CT COLONOGRAPHY 81

TABLE 22 U.S. MARKET FOR CT COLONOGRAPHY, THROUGH 2014 ($ MILLIONS) 81

AUTOMATED SKIN CANCER DETECTION 82

TABLE 23 U.S. MARKET FOR AUTOMATED SKIN CANCER DETECTION SYSTEMS, THROUGH 2014 ($ MILLIONS) 82

Chapter-7: PROPHYLAXIS: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 83

FIGURE 14 U.S. MARKET FOR NEW VACCINES, 2008-2014 ($ MILLIONS) 83

TECHNOLOGIES 84

FLU VACCINES 84

Bird Flu Vaccine 85

Swine Flu Vaccine 85

MENINGOCOCCAL VACCINES 85

COMBINED TETANUS-DIPHTHERIA-PERTUSSIS VACCINES 86

HUMAN PAPILLOMA VIRUS VACCINE 87

OTHER NEW VACCINES 88

MMR/Varicella Vaccine 88

Rotavirus Vaccines 89

Shingles Vaccine 89

MARKETS 90

SUMMARY 90

FIGURE 15 U.S. MARKET FOR NEW HUMAN VACCINES, 2008 (%) 90

FIGURE 15 (CONTINUED) 91

TABLE 24 U.S. MARKET FOR NEW VACCINES, THROUGH 2014 ($ MILLIONS) 91

FLU VACCINES 91

TABLE 25 U.S. PURCHASES OF NOVEL FLU VACCINES, THROUGH 2014 ($ MILLIONS) 92

MENINGOCOCCAL VACCINES 92

TABLE 26 U.S. MARKET FOR MENINGOCOCCAL VACCINES, THROUGH 2014 ($ MILLIONS) 92

TDAP VACCINES 93

TABLE 27 U.S. MARKET FOR TDAP VACCINES, THROUGH 2014 ($ MILLIONS) 93

HPV VACCINES 93

TABLE 28 U.S. MARKET FOR HPV VACCINES, THROUGH 2014 ($ MILLIONS) 94

OTHER NEW VACCINES 94

MMR/Varicella 94

TABLE 29 U.S. MARKET FOR OTHER NEW VACCINES, THROUGH 2014 ($ MILLIONS) 95

Rotavirus 95

Shingles 95

Chapter-8: PREVENTING THERAPEUTIC ERRORS AND FAILURES: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 96

FIGURE 16 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008-2014 ($ MILLIONS) 96

TECHNOLOGIES 97

CLINICAL DECISION AIDS AND OTHER INFORMATION TECHNOLOGIES 97

Electronic Prescribing 97

Software 97

Software (Continued) 98

Software (Continued) 99

Mobile Interface Devices 100

Electronic Data Interchange 100

TABLE 30 E-PRESCRIPTION SOFTWARE VENDORS 101

Computerized Provider Order Entry Systems 101

Computerized Provider ... (Continued) 102

TABLE 31 CPOE TECHNOLOGY VENDORS 103

Clinical Decision Support Systems 103

TABLE 32 CLINICAL DECISION SUPPORT TECHNOLOGY VENDORS 104

MEDICATION FORMULATION, DISPENSING, AND PACKAGING SYSTEMS 104

Automated Prescription Formulation/Dispensing Systems 105

Packaging Machines 105

Tablet Counters 105

Unit-Dose or Blister Pack Repackaging and Dispensing Systems 105

Intravenous Compounders 106

Dispensing Systems 106

Centralized Dispensing Systems 106

Automated Medication Carts 106

Decentralized Dispensing Devices 106

Smart Infusion Pumps 107

TABLE 33 SUPPLIERS OF AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS 108

Packaging 108

Bottle Cap Medication Reminder 109

Medication Label Reader for the Visually Impaired 109

MARKETS 110

SUMMARY 110

TABLE 34 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 110

FIGURE 17 THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008-2014 (%) 111

ELECTRONIC PRESCRIBING 111

TABLE 35 U.S. MARKET FOR ELECTRONIC PRESCRIBING TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 112

FIGURE 18 U.S. ELECTRONIC PRESCRIPTION MARKET SEGMENTS (%) 113

COMPUTERIZED PROVIDER ORDER ENTRY 113

TABLE 36 NUMBER OF U.S. HOSPITALS WITH COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2007 114

TABLE 37 U.S. MARKET FOR COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2014 ($ MILLIONS) 114

COMPUTERIZED DECISION SUPPORT 114

TABLE 38 U.S. MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, THROUGH 2014 ($ MILLIONS) 115

AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING 115

TABLE 39 U.S. MARKET FOR HOSPITAL/INPATIENT AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS, THROUGH 2014 ($ MILLIONS) 115

SMART INFUSION PUMPS 115

TABLE 40 U.S. MARKET FOR SMART INFUSION PUMPS, THROUGH 2014 ($ MILLIONS) 116

SMART PACKAGING 116

TABLE 41 U.S. MARKET FOR SMART PACKAGING TO PREVENT MEDICATION ERRORS, THROUGH 2014 ($ MILLIONS) 116

Smart Packaging (Continued) 117

Chapter-9: CHRONIC DISEASE MANAGEMENT: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 118

FIGURE 19 U.S. MARKET FOR ADVANCED CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS) 118

TECHNOLOGIES 119

MONITORING 119

Blood Pressure Monitors 119

Blood Pressure Monitors (Continued) 120

Glucose Monitors 120

Glucose Monitors (Continued) 121

Cholesterol Monitors 122

Cardiac Monitors 122

Asthma Monitors 123

Pervasive Monitoring 123

Embedded Monitors 124

Wearable Monitors 124

Wireless Telemetry 125

Cellular Networks 126

Bluetooth 126

Other Technologies 126

Suppliers 127

TABLE 42 SUPPLIERS OF ADVANCED TECHNOLOGIES FOR MONITORING CHRONIC DISEASES 127

THERAPEUTIC DEVICES 127

Insulin Administration Devices 128

Insulin Pumps 128

Insulin Inhalers 129

Suppliers 130

TABLE 43 SUPPLIERS OF ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASES 130

COMMERCIAL CHRONIC DISEASE MANAGEMENT SERVICES 130

Commercial Chronic Disease ... (Continued) 131

Suppliers 132

TABLE 44 CHRONIC DISEASE MANAGEMENT ORGANIZATIONS 132

MARKETS 132

SUMMARY 132

TABLE 45 MARKET FOR CHRONIC DISEASE MANAGEMENT TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 133

FIGURE 20 CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES MARKET SHARES, 2008-2014 (%) 133

FIGURE 20 (CONTINUED) 134

MONITORING 134

TABLE 46 MARKET FOR ADVANCED MONITORING TECHNOLOGIES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS) 134

Advanced Sensors 134

TABLE 47 U.S. MARKET FOR ADVANCED NONINVASIVE SENSORS, THROUGH 2014 ($ MILLIONS) 135

Pervasive Monitoring 135

TABLE 48 HOME MONITORING AND TELEMETRY SALES, THROUGH 2014 ($ MILLIONS) 135

Telemetry 136

TABLE 49 SALES OF HOME TELEMETRY MONITORS, THROUGH 2014 ($ MILLIONS) 136

THERAPEUTIC DEVICES 136

TABLE 50 MARKET FOR ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS) 137

Insulin Pumps 137

TABLE 51 MARKET FOR INSULIN PUMPS, THROUGH 2014 ($ MILLIONS) 137

TABLE 52 INSULIN PUMP SALES, THROUGH 2014 (NUMBER OF PUMPS/$ MILLION) 138

Insulin Inhalers 138

TABLE 53 MARKET FOR INSULIN INHALERS, THROUGH 2014 ($ MILLIONS) 138

DISEASE MANAGEMENT SERVICES 139

TABLE 54 MARKET FOR COMMERCIAL DM SERVICES, THROUGH 2014 ($ MILLIONS) 139

Chapter-10: APPENDIX

APPENDIX A: COMPANY PROFILES 140

EARLY DETECTION AND SCREENING 140

COMPUTERIZED SCREENING INC. 140

CORRELOGIC SYSTEMS, INC. 140

DILON TECHNOLOGIES 141

GAMMA MEDICA-IDEAS, INC. 141

ICAD INC. 141

MYRIAD GENETICS, INC. 142

NOVX SYSTEMS INC. 142

POLARTECHNICS LTD. 143

STREETIME TECHNOLOGIES 143

U-SYSTEMS, INC. 143

VERMILLION, INC. 144

VIATRONIX, INC. 145

PROPHYLAXIS 145

MERCK & CO., INC. 145

ERROR PREVENTION 146

BAXA CORP. 146

DRFIRST.COM 146

LIFECOM, INC. 146

MASSACHUSETTS GENERAL HOSPITAL 147

OMNICELL, INC. 147

SCRIPTPRO 148

SIGMA INTERNATIONAL GENERAL MEDICAL APPARATUS LLC 148

SURESCRIPTS LLC 149

THERADOC INC. 149

CHRONIC DISEASE MANAGEMENT 150

ALERE 150

CARD GUARD AG 150

ECHO THERAPEUTICS, INC. 151

HEALTH FRONTIER, INC. 151

HEALTHWAYS, INC. 152

MANNKIND CORP. 152

MEDTRONIC MINIMED INC. 152

MICRODOSE THERAPEUTX, INC. 153

OMRON HEALTHCARE, INC. 153

PFIZER INC. 153

PREMD INC. 154

T+ MEDICAL AMERICAS 154

U.S. PREVENTIVE MEDICINE 155

VECTURA GROUP PLC 156

VIVOMETRICS INC. 156

APPENDIX B: PATENT ANALYSIS 157

FIGURE 21 U.S. PATENTS RELATED TO NEW PREVENTIVE HEALTHCARE TECHNOLOGIES (%) 157

To order this report:

Preventive Healthcare Technologies, Products and Markets

http://www.reportlinker.com/p0157458/Preventive-Healthcare-Technologies-Products-and-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Source PR Newswire


www.prnewswire.co.uk

Browse news from 2009

Download PDF